Pancreatic Neuroendocrine Incidentalomas: When is Surgery in the Patient’s Best Interests? Abstract #1209

Introduction: Small PNETs, many of which are diagnosed incidentally, pose a management dilemma. Whilst resection offers curative outcomes, the risks of surgery have led many to adopt surveillance strategies. 2cm is often used as a threshold for malignancy, but reports suggest that this value may not be valid.
Aim(s): To investigate the predictors of malignancy in small PNETs
Materials and methods: The notes of 233 patients with PNETs of all stages were reviewed for pathology reports. Tumours were defined as malignant if displaying local invasion, vascular invasion, nodal involvement or distant metastasis (metachronous or synchronous). Predictors of malignancy were considered using logistic regression.
Conference: 12th Annual ENETS Conference (2015)
Category: Surgical treatment
Presenting Author: Logan Mills
Keywords: PNET

To read results and conclusion, please login ...

Further abstracts you may be interested in

#890 Prognostic Validity of the WHO 2010 TNM Staging and Grading Criteria for Pancreatic Neuroendocrine Tumors
Introduction: The TNM staging and grading system developed by the WHO was designed to help prognosticate patients.
Conference: 11th Annual ENETS Conference (2014)
Category: Pathology, grading, staging
Presenting Author: Mr Logan E Mills
#1777 Tumour Size Is Not a Reliable Criterion for Resection of Patients with Non-Secreting Pancreatic Neuroendocrine Tumours: Results of an International, Multi-Centre, Operative Cohort
Introduction: Small pancreatic neuroendocrine tumours (pNETs) present a management dilemma between surveillance and resection.
Conference: 14th Annual ENETS conference (2017)
Category: Surgical treatment
Presenting Author: Logan Mills
#893 The Role of Primary Resection and Hepatic Resection in the Management of Metastatic Pancreatic Neuroendocrine Tumors with Irresectable Liver Metastases
Introduction: More than 40% of pancreatic neuroendocrine tumor (PNET) patients have liver metastases (LM) at diagnosis. Whilst it is agreed that, where possible, curative surgery offers the best outcomes, the role of debulking surgery in the context of irresectable LM remains unclear.
Conference: 11th Annual ENETS Conference (2014)
Category: Surgical treatment
Presenting Author: Mr Logan E Mills
Keywords: liver
#1239 Histological Classification of Pancreatic Neuroendocrine Tumours: Optimising the Ki67 System
Introduction: Pancreatic neuroendocrine tumours are graded using the Ki67 antigen in accordance with the WHO 2010 classification. Despite the system’s widespread use, a wide variety of tumour behaviours have been described leading to various proposed revisions.
Conference: 12th Annual ENETS Conference (2015)
Category: Pathology, grading, staging
Presenting Author: Logan Mills
Keywords: G3
#1233 CA 19-9: A Novel Role in the Prognosis of Pancreatic Neuroendocrine Tumors
Introduction: Prognostication is difficult for neuroendocrine tumours given their long survival. Staging, grading using Ki67 and receptor status are tools commonly used, but are not without their limitations. CA 19-9 is a tumour marker used in the diagnosis and follow-up of pancreatic adenocarcinomas despite multiple confounding factors, including jaundice. CA 19-9 is not useful in the diagnosis of PNETs having a sensitivity of only 19%, but it is not known whether it has other roles in PNETs.
Conference: 12th Annual ENETS Conference (2015)
Category: Biomarkers
Presenting Author: Logan Mills
Authors: Mills L, Ramage J, Quaglia A, Basuroy R, ...
Keywords: CA 19-9